ATE120460T1 - Neue acetohydroxamsäureverbindung, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindung und arzneimittel. - Google Patents
Neue acetohydroxamsäureverbindung, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindung und arzneimittel.Info
- Publication number
- ATE120460T1 ATE120460T1 AT92111427T AT92111427T ATE120460T1 AT E120460 T1 ATE120460 T1 AT E120460T1 AT 92111427 T AT92111427 T AT 92111427T AT 92111427 T AT92111427 T AT 92111427T AT E120460 T1 ATE120460 T1 AT E120460T1
- Authority
- AT
- Austria
- Prior art keywords
- medicinal products
- compound
- acetohydroxamic acid
- acid compound
- producing
- Prior art date
Links
- -1 ACETOHYDROXAMIC ACID COMPOUND Chemical class 0.000 title abstract 3
- 229960001171 acetohydroxamic acid Drugs 0.000 title abstract 3
- 229940126601 medicinal product Drugs 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000002923 oximes Chemical class 0.000 abstract 2
- RBIGKSZIQCTIJF-UHFFFAOYSA-N 3-formylthiophene Chemical compound O=CC=1C=CSC=1 RBIGKSZIQCTIJF-UHFFFAOYSA-N 0.000 abstract 1
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 abstract 1
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 abstract 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 abstract 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 239000001116 FEMA 4028 Substances 0.000 abstract 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- 229910052796 boron Inorganic materials 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- HHKRHJJLCBYPSJ-UHFFFAOYSA-N n-(thiophen-3-ylmethyl)hydroxylamine Chemical compound ONCC=1C=CSC=1 HHKRHJJLCBYPSJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4123613A DE4123613C1 (enExample) | 1991-07-17 | 1991-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE120460T1 true ATE120460T1 (de) | 1995-04-15 |
Family
ID=6436313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92111427T ATE120460T1 (de) | 1991-07-17 | 1992-07-06 | Neue acetohydroxamsäureverbindung, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindung und arzneimittel. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5252562A (enExample) |
| EP (1) | EP0523499B1 (enExample) |
| AT (1) | ATE120460T1 (enExample) |
| AU (1) | AU644533B2 (enExample) |
| CA (1) | CA2070492A1 (enExample) |
| DE (2) | DE4123613C1 (enExample) |
| DK (1) | DK0523499T3 (enExample) |
| ES (1) | ES2073214T3 (enExample) |
| GR (1) | GR3015673T3 (enExample) |
| HK (1) | HK1005189A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1954320A2 (en) * | 2005-11-15 | 2008-08-13 | Baxter International Inc. | Compositions comprising lipoxygenase inhibitors and cyclodextrin |
| EP4008327A1 (en) | 2009-04-29 | 2022-06-08 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0196184B1 (en) * | 1985-03-16 | 1992-09-16 | The Wellcome Foundation Limited | Aryl derivatives |
| IE59397B1 (en) * | 1985-03-16 | 1994-02-23 | Wellcome Found | New aryl derivatives |
| GB8531839D0 (en) * | 1985-12-30 | 1986-02-05 | Wellcome Found | Aryl derivatives |
| GB8531838D0 (en) * | 1985-12-30 | 1986-02-05 | Wellcome Found | Aryl derivatives |
| US5036157A (en) * | 1986-03-11 | 1991-07-30 | Burroughs Wellcome Co. | Aryl derivatives |
| US5026729A (en) * | 1987-02-10 | 1991-06-25 | Abbott Laboratories | Lipoxygenase inhibiting compounds |
| CA1316935C (en) * | 1987-12-09 | 1993-04-27 | Hiromitsu Saito | Hydroxamic acid derivatives |
| EP0351214A1 (en) * | 1988-07-14 | 1990-01-17 | The Wellcome Foundation Limited | Anti-inflammatory aryl derivatives |
| EP0412939A3 (en) * | 1989-08-11 | 1991-09-04 | Ciba-Geigy Ag | Certain benzopyran and benzothiopyran derivatives |
| FR2660309B1 (fr) * | 1990-03-27 | 1992-07-17 | Roussel Uclaf | Nouveaux complexes de l'acide tiaprofenique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs derives. |
-
1991
- 1991-07-17 DE DE4123613A patent/DE4123613C1/de not_active Expired - Fee Related
-
1992
- 1992-06-04 CA CA002070492A patent/CA2070492A1/en not_active Abandoned
- 1992-07-06 DE DE59201764T patent/DE59201764D1/de not_active Expired - Lifetime
- 1992-07-06 DK DK92111427.8T patent/DK0523499T3/da active
- 1992-07-06 EP EP92111427A patent/EP0523499B1/de not_active Expired - Lifetime
- 1992-07-06 ES ES92111427T patent/ES2073214T3/es not_active Expired - Lifetime
- 1992-07-06 AT AT92111427T patent/ATE120460T1/de not_active IP Right Cessation
- 1992-07-10 US US07/911,623 patent/US5252562A/en not_active Expired - Lifetime
- 1992-07-16 AU AU20360/92A patent/AU644533B2/en not_active Ceased
-
1995
- 1995-04-03 GR GR950400817T patent/GR3015673T3/el unknown
-
1998
- 1998-05-19 HK HK98104298A patent/HK1005189A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GR3015673T3 (en) | 1995-07-31 |
| CA2070492A1 (en) | 1993-01-18 |
| US5252562A (en) | 1993-10-12 |
| DE59201764D1 (de) | 1995-05-04 |
| EP0523499B1 (de) | 1995-03-29 |
| ES2073214T3 (es) | 1995-08-01 |
| DE4123613C1 (enExample) | 1993-02-04 |
| AU644533B2 (en) | 1993-12-09 |
| DK0523499T3 (da) | 1995-06-12 |
| HK1005189A1 (en) | 1998-12-24 |
| AU2036092A (en) | 1993-01-28 |
| EP0523499A1 (de) | 1993-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE1288T1 (de) | Amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel. | |
| GB2037745B (en) | Diphenylbutyl - piperazinecarboxamides | |
| GR3019957T3 (en) | Derivatives of substituted cyclohexane, their process of preparation and their application with the treatment of diseases | |
| ATE177950T1 (de) | Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis | |
| DE3878790D1 (de) | Organo-anorganische vanadyl-verbindung, verfahren zur herstellung einer solchen verbindung, pharmazeutische zusammensetzung, die diese organo-anorganische verbindung enthaelt. | |
| KR850000451A (ko) | 결정성 나트륨 아목시실린의 제조방법 | |
| ATE120460T1 (de) | Neue acetohydroxamsäureverbindung, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindung und arzneimittel. | |
| SE7902858L (sv) | Medicin innehallande ett derivat av para-aminobensoesyra sasom aktiv bestandsdel | |
| ATE119519T1 (de) | Substituierte phenylacetylene, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel. | |
| FI873892A0 (fi) | Nya derivat av dihydro-oxazol, foerfarande foer deras framstaellning och deras anvaendning. | |
| DE3852526D1 (de) | Neue pharmazeutische Präparate sowie neue Lactosylverbindungen und ihre Herstellung. | |
| ATE124035T1 (de) | Substituierte 3,4-dihydronaphthaline, diese verbindungen enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen. | |
| ATE10743T1 (de) | Benzopyranylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel und zwischenprodukte. | |
| ATE66920T1 (de) | Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten. | |
| DE3881484D1 (de) | Optisch aktive produkte von 20,21-dinoreburnamenin-derivaten, verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen. | |
| DE3461187D1 (en) | N-cyclopropylmethyl-2-oxo-3-diparamethoxyphenyl-5,6-triazines, process for its preparation and their use as pharmaceutical preparations | |
| ATE753T1 (de) | Neue substituierte 2-phen ylamino-1,3-tetrahydropyrimidine-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben. | |
| NZ218892A (en) | Nitrogen-arylmethoxy thiophene derivatives and pharmaceutical compositions | |
| ATE13676T1 (de) | Delta-1,3,5-3-chlor-11-beta,16-alpha,17-alpha,2 - tetra-(hydroxy)-pregnan-20-on-16,17acetonidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
| CH505058A (de) | Verfahren zur Herstellung von Monohydrat der 4-Dimethylamino-1,4,4a,5,5a,6,11,12a-Oktahydro-3,6,10,12,12a-Pentahydroxy-6-Methyl-1,11-Dioxonaphthacen-2-Karboxamido-N-Methylaminoessigsäure | |
| PT73789B (de) | Neue cephalosporine verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| ATE225T1 (de) | Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben. | |
| FR2373539A1 (fr) | Derives de l'acide dithiocarbamique, leur procede de preparation et leur application en medecine veterinaire | |
| KR930000116A (ko) | 돼지 흉막 폐렴 예방/치료 조성물 | |
| ES8201996A1 (es) | Procedimiento para la preparacion de acidos 2,4-diamino-5- sulfamoilbenzosulfonicos sustituidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |